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Background and aims: Given the unexplored potential of physical activity to reduce the 
progression of cerebral small vessel disease (cSVD), the purpose of this study was to 
prospectively (across 9-year follow-up) examine the relation between (baseline) physical 
activity and the (clinical and imaging) consequences of the whole spectrum of cSVD. 
Methods: 503 Patients with cSVD from the RUNDMC study were followed for 9 years. 
Physical activity was assessed using a questionnaire in 2006, 2011 and 2015. Clinical events 
(i.e. all-cause mortality, cerebrovascular events (by stroke subtype) were collected with a 
structured questionnaire. Patients underwent MRI scanning for the assessment of MRI-markers 
of cSVD (i.e. white matter hyperintensities, lacunes and microbleeds) and microstructural 
integrity of the white matter at three timepoints.  
Results: The mean age at baseline was 66 (SD 9.0) years; 44% were women. A higher baseline 
physical activity level was independently associated with a lower all-cause mortality (HR: 0.69, 
95%CI: 0.49-0.98, p=0.03) and incidence of cerebrovascular disease (HR: 0.58, 95%CI: 0.36-
0.96, p=0.03). However, we found no relation between physical activity and incident lacunar 
stroke or progression of MRI markers of cSVD. 
Conclusions: Whilst regular physical activity was not related to the progression of MRI 
markers of cSVD across a 9-year follow-up, results from our study prove that high levels of 
physical activity in patients with cSVD are associated with a lower all-cause mortality and 








Cerebral small vessel disease (cSVD) refers to a group of several pathological processes 
affecting the small arteries, arterioles, capillaries and venules of the brain.1-3 Patients with cSVD 
are at an increased risk of clinical symptomatic cerebrovascular disease (i.e. stroke and transient 
ischemic attack (TIA)) and vascular dementia, ultimately causing (long-term) disability and 
mortality4, 5. Given the small size of these affected vessels, they cannot be visualized in-vivo 
individually. However, the presumed consequences of cSVD can be visualized on conventional 
MRI and diffusion tensor imaging (DTI) ranging from generalized brain atrophy, white matter 
hyperintensities (WMH) and lacunes of presumed vascular origin to lower microstructural 
integrity 6, 7.  
Unfortunately, there is no proven effective treatment to attenuate the progression of cSVD, 
which emphasizes the need for the identification of new treatable targets. Given its ability to 
improve vascular risk factors that are related to cSVD8, 9, physical activity (PA) may potentially 
be an effective strategy in preventing clinical events and/or progression of cSVD. In support of 
this hypothesis, one study has found better microstructural integrity (i.e. higher fractional 
anisotropy (FA) and lower mean diffusivity (MD)) and fewer white matter hyperintensities 
(WMH) in physically active cSVD patients compared to their sedentary peers10. An important 
limitation of this latter study was the cross-sectional nature, which complicates the 
determination of direction of causality. Moreover, the effects of PA likely take a long period 
(i.e. months to years),8, 9 highlighting the need to examine the impact of PA on clinical events 
and progression of  cSVD disease using a longitudinal design.  
 





Therefore, the aim of this study was to examine both the cross-sectional and prospective (across 
9-year follow-up) relation between baseline PA and the development of clinical events and MRI 
markers of cSVD to assess progression of the disease. We hypothesized, following the results 
from cross-sectional observations, that higher levels of PA are also longitudinally related to 
fewer clinical events,  slower progression of MRI markers of cSVD and better preservation of 




Patients with cSVD were included for the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUNDMC) study, a prospective study that investigates 
risk factors and clinical consequences of cSVD. Inclusion of these individuals was performed 
in 2006, with follow-up measurements in 2011 and 2015. All participants signed an informed 
consent form. The study has been approved by the relevant ethical committee (CMO Arnhem-
Nijmegen). 
In 2006, patients with symptomatic cSVD referred to the Department of Neurology of the 
Radboud university medical centre (Radboudumc) between October 2002 and November 2006 
were selected for participation. Inclusion criteria were 1) age between 50 and 85 years, and 2) 
established cSVD, either based on neuroimaging (WMH and/or lacunar infarcts) or on a lacunar 
syndrome >6 months after the event. Exclusion criteria were 1) dementia (American Psychiatric 
Association, 2000); 2) Parkinson(ism); 3) intracranial haemorrhage; 4) life expectancy of < 6 
months; 5) intracranial space occupying lesions; 6) (psychiatric) disease interfering with 
cognitive testing or follow-up; 7) recent or current use of acetylcholine-esterase inhibitors, 





lesion mimics (e.g. multiple sclerosis); 9) prominent visual or hearing impairment; 10) language 
barrier; and 11) MRI contra-indications or known claustrophobia. From 1,004 invited patients, 
727 were eligible for participation. Ultimately, 525 individuals agreed to participate and signed 
informed consent. A total of 22 individuals were excluded during these tests, as exclusion 
criteria were found during this visit. Complete information, including a cerebral MRI scan, was 
obtained for 503 individuals. These participants reported (a combination of) symptoms 
consisting of TIA or lacunar syndrome (n=219), cognitive disturbances (n=245), motor 
disturbances (n=97) and/or depressive symptoms (n=100). Baseline characteristics and vascular 
risk factors for all patients were extracted from the RUNDMC database.  
 
Assessment of physical activity 
Physical activity was prospectively assessed in 2006, 2011 and 2015 with a questionnaire that 
has been proven valid and useful in other large studies11, 12. Subjects reported the average 
amount of time per week during the past year spent on the following physical activities: running 
(>10 km/hour), jogging (<10 km/hour), walking outdoors, racquet sports, swimming, cycling, 
aerobic fitness, other vigorous activities (e.g. vacuum cleaning) and low intensity exercise (e.g. 
yoga, stretching). A metabolic equivalent (MET) value was assigned to each physical activity 
following accepted guidelines13, which allowed for the calculation of the total volume of 
physical activity. For this purpose, physical activity (in METhours) was calculated by 
multiplying its associated MET-value by the time (in hours) this physical activity was 
performed per week. This resulted in a total MET-score for each participant representing the 
total volume of physical activity. Thereafter, patients were divided into active (50% most active 
participants, based on baseline MET-score) and inactive participants (50% least active 







Clinical events consisted of all-cause mortality and incidence of cerebrovascular events (i.e. a 
composite endpoint consisting of all TIA’s, ischemic strokes, hemorrhagic stroke and vascular 
dementia). Cerebrovascular events were thereafter divided by cause of stroke (lacunar events 
(i.e. lacunar TIA and lacunar stroke) and other causes of stroke (e.g. large artery disease or 
cardio-embolic origin)). All incident events were actively retrieved from patients during follow-
up and verified using information from patient records. From participants who were not 
available for follow-up assessment, medical records were reviewed; in addition, their general 
practitioner and medical specialists were contacted for information on clinical events and their 
cognitive status. The onset of clinical events was defined as the date on which the event was 
diagnosed by either the general practitioner or medical specialist. The diagnosis of dementia 
was based on the Diagnostic and Statistical Manual of Mental Disorders (IV)14. Vascular 
dementia was based on NINDS-AIREN criteria15 and probable Alzheimer’s disease was based 




MRI images were acquired at 3 time points (2006, 2011 and 2015) on a 1.5 tesla scanner (2006: 
Siemens [Munich, Germany], Magnetom Sonata; 2011 and 2015: Siemens, Magnetom 
Avanto). The protocol included a 3-dimensional T1 magnetization-prepared rapid gradient-
echo sequence (voxel size 1.0 X 1.0 X 1.0 mm), a fluid-attenuated inversion recovery (FLAIR) 
sequence (voxel size 1.0 X 1.2 X 5.0 mm, interslice gap 1.0 mm; follow up: voxel size 1.2 X 





time/echo time = 10.100/93 milliseconds; voxel size 2.5 X 2.5 X 2.5 mm). Full acquisition 
details have been described previously17.  
 
Assessment of MRI-markers for cSVD.  
cSVD was rated according to the Standards for Reporting Vascular Changes on neuroimaging 
(STRIVE) criteria7. The presence of WMHs, lacunes and microbleeds was manually assessed 
for each patient, which allowed for the generation of an SVD score as previously described18. 
Because periventricular space data was not available, this score is based on the presence of 
WMHs (with >1 Fazekas score), lacunes and cerebral microbleeds (for each: 0= not present, 
1=present). The SVD score therefore had a range from 0 to 3. Additionally, WMH volume was 
calculated by a semiautomatic segmentation method which has been described in detail 
elsewhere19. Segmentations were visually checked for errors by a trained rater who was blinded 
to clinical information. Total WMH volume was calculated by summing the segmented areas 
multiplied by slice thickness. Intracranial volume was determined by summing the total volume 
of grey matter, white matter and cerebral spinal fluid. Finally, to account for interscan effects, 
relative WMH volume (adjusted for baseline intracranial volume) was calculated for each 
individual patient. WMH volume, SVD score and number of microbleeds and lacunes were 
assessed for each patient in 2006, 2011 and 2015, allowing the determination of changes in 
these MRI-markers over time. 
 
Assessment of microstructural integrity.  
DTI pre-processing was described in detail in a previous article10. After pre-processing, the 
volume-averaged fractional anisotropy (FA) and mean diffusivity (MD) were calculated in the 





visually checked for motion artefacts and co-registration errors. For the DTI analysis, 440 
subjects were included after additional exclusion of 63 patients because of excessive motion 
artefacts or the presence of territorial infarcts. These data were imported into the RUNDMC 
database and extracted for analysis in 2019.  
 
Statistical analyses 
Analyses were performed using RStudio (R Core Team (2019))20. All MRI based outcome 
measures were checked for normality to decide for parametric or non-parametric analyses. 
Statistical significance was set at P<0.05.  
To examine the prospective relation between PA and clinical events, we first examined the 
association between baseline PA and all-cause mortality and incidence of cerebrovascular 
events using a cox proportional regression analysis. Patients who died were censored. Second, 
we analysed the cross-sectional relation between baseline PA and MRI-markers of SVD (i.e. 
SVD score, lacunes, microbleeds, and WMH volume) and white matter microstructure (i.e. MD 
and FA) with either linear or logistic regression, when appropriate. Third, the association 
between baseline PA and changes in MRI-markers and white matter microstructure (for each 
participant) during 9-year follow-up was investigated with linear mixed models. Linear mixed 
models were performed using the lme4 package21 with random intercept and an interaction term 
for group and time to investigate the relation between baseline PA and progression of cSVD.  
All statistical analyses were first performed univariate (with only the PA group as independent 
variable), followed by a multivariate analysis with adjustment for possible confounders at 
baseline (i.e. age, gender, level of education, normalized total brain volume, executive function, 
and cardiovascular risk factors (hypertension, body mass index (BMI), diabetes mellitus, use 







Table 1 presents the baseline characteristics of the 503 patients, divided into the physically 
active and inactive group. Compared to the inactive group, the active group was significantly 
younger, had a higher total brain volume, had a lower prevalence of hypertension and diabetes, 
and a lower systolic blood pressure and BMI (table 1). The 9-year follow-up clinical data was 
available for all patients. Complete MRI data was available for 282 patients (figure 1). 
Participants reported a median METhours/week of 97 (IQR: 78-136) and 37 (IQR:22-48) in 
respectively the active and inactive group. In both groups, the total MET-score decreased 
significantly across the 9-year follow-up (P<0.001), but total MET-score remained significantly 
higher in the active group than the inactive group (table 1).  
 
Baseline physical activity and the risk of cerebrovascular events 
During 9-year follow-up 92 patients died (32 in the active group vs 60 in the inactive group). 
A higher baseline PA was independently associated with a lower all-cause mortality (adjusted 
HR: 0.69, 95%CI: 0.49-0.98, p=0.03) (Figure 2). Furthermore, 74 patients were diagnosed with 
a cerebrovascular event (26 in the active group vs 48 in the inactive group). A higher baseline 
PA was independently associated with this composite incidence of all cerebrovascular events 
(adjusted HR: 0.58, 95%CI: 0.36-0.96, p=0.03). However, when divided into lacunar (n=12 vs 
15, HR: 0.83, 95%CI: 0.38-1.83, p=0.65) and non-lacunar events (n=10 vs 18, HR: 0.77, 
95%CI: 0.34-1.73, p=0.53), there was no significant association between baseline PA and the 
risk of the causes of stroke.  
 





Cross-sectionally the SVD-score was significantly lower in the active group (median: 1 vs 2, 
p=<0.01), which was mainly due to a lower presence of lacunes in the physically active group 
(OR: 0.46, 95%CI: 0.30-0.67, p=<0.001). After correction for confounders, this difference 
disappeared (Table 2). WMH volume at baseline was significantly lower in the active group 
compared to the inactive group (median: 3.0 ml vs 4.5 ml, p=0.03). However, after adjustment 
for confounders this association disappeared (Table 2). Finally, with linear mixed models no 
independent relation was found between PA and the cSVD-related MRI-markers across 9-year 
follow-up (Table 3). There was no independent association between PA and any of the markers 
of microstructural integrity, both at the cross-sectional and prospective level (Table 4 and Table 
5).   
 
Discussion 
We found that higher volumes of baseline PA in patients with cSVD related to a lower all-cause 
mortality and reduced incidence of all cerebrovascular events compared to patients with a lower 
baseline PA, across 9-year follow-up. However, we found no such association with lacunar 
stroke and MRI markers for cSVD.  
It is well established that a higher PA can act as an effective strategy for prevention of 
(progression of) cardiovascular disease in various clinical populations 22-25. To date, however, 
the longitudinal association between PA and clinical outcomes and MRI markers of SVD has 
never been explored in cSVD patients. The long follow-up of 9-years allowed us to detect the 
clinical impact of baseline PA, which confirmed our hypothesis that higher levels of PA at 
baseline is strongly associated with better clinical outcome (mortality and cerebrovascular 
events). This observation fits with the observation that prolonged adherence to high levels of 





activity and stroke subtype (i.e. lacunar events and other causes of stroke). However, the results 
of this sub analysis might be underpowered due to the low incidence of these stroke subtypes 
(27 lacunar events and 28 other causes of stroke respectively). Taken together, our data provide 
strong support for the relation between high levels of PA and protective clinical benefits in 
patients with cSVD, even after the diagnosis is made. Contrary to our hypothesis, higher PA 
volumes were not associated with the (clinical) presentation of cSVD (i.e. lacunar events, MRI-
markers of cSVD). Although higher WMH volumes were present in patients with high levels 
of PA at baseline, this appeared to be confounded by age and total brain volume. Our 
observations are in contrast with others that report an association between PA and both MRI-
markers and microstructural integrity in healthy older adults and cSVD patients10, 26, 27. 
However, these previous studies were cross-sectional, in which reverse causality may have 
played a role in explaining the observations. The fact that the relation between PA and WMH 
volume and SVD-score disappeared upon correcting for potential confounders, but also 
across/over time, highlights the importance to adjust for these factors and to adopt a prospective 
design. These observations suggest that other factors, independent from PA, may be more 
important contributors to the progression of MRI markers of cSVD in symptomatic cSVD 
patients.  
Our finding that individuals with higher volumes of PA showed a lower incidence of 
cerebrovascular events, without affecting markers of cSVD (i.e. lacunar events or MRI 
markers), raises questions about the potential underlying mechanisms. A frequently discussed 
explanation for the protective effects of PA on cardiovascular health is that the repeated increase 
in perfusion of large arteries28, results in improved cardiovascular health and a lower incidence 
of cardiovascular disease and all-cause mortality. Several studies have provided strong evidence 
for a role of perfusion in protecting against clinical events in large and resistance arteries28. 





increases in cerebral perfusion in small cerebral arteries during exercise.29 Although previous 
evidence shows that higher PA is related to an increased cerebral perfusion30, the relative 
increase in perfusion of the brain during PA is modest compared to other organs, such as the 
heart31-33. Possibly, this may explain our observation that physical activity protects against 
cardio- and cerebrovascular morbidity, whilst no protective effects are found in the (small) 
arteries of the brain. To further investigate this hypothesis studies are required to better 
understand the causal impact of PA on microvascular perfusion and relate this to clinical 
outcome  
 
Strengths and limitations.  
Strong elements of this study include its large sample size and prospective design. Furthermore, 
a structured assessment of physical activity and risk factors was used and all associations were 
corrected for possible confounders which have been described to be strongly related to cSVD 
progression and brain structure34. However, some methodological issues need to be considered. 
Firstly, due to the observational nature of this study it is impossible to determine a causal 
relation and therefore results should be considered with caution. To further investigate our 
promising results, we would recommend to initiate a randomized clinical trial to investigate the 
causal effects of PA in patients with cSVD. Several early phase trials that incorporate exercise 
intervention to reduce the progression of cSVD are currently underway35. Secondly, although 
structured questionnaires were used to assess physical activity, the amount of METhours/week 
reported may not reflect the exact amount of energy expended. Overestimation of PA with the 
use of questionnaires is a common finding. However, it is still a frequently used, feasible and 
valid method for the assessment of PA in large sample studies, especially to detect changes over 
time36. Therefore, to be able to make a more reliable distinction between “active” and “inactive” 







Whilst regular physical activity was not related to the progression of MRI markers of cSVD 
across a 9-year follow-up, results from our study prove that high levels of physical activity in 
patients with cSVD are associated with a lower all-cause mortality and lower incidence of 
cerebrovascular events. This work supports the importance for increasing levels of physical 
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Table 1. Baseline characteristics 
Table 2. The effect of PA on MRI-markers – cross-sectional 
Table 3. The effect of PA on MRI-markers - longitudinal 
Table 4. The effect of PA on microstructural integrity – cross-sectional 















Age – yr 64.2  (±8.6) 67.0 (±8.7) <0.001 
Male sex 138 (55%) 146 (58%) 0.51 
Education† 228 (91%) 226 (90%) 0.66 
Total brain volume – ml 1076 (±79) 1046 (±79) <0.001 
Medical history    
           Atrial fibrillation 15 (6%) 25 (10%) 0.10 
           Hypertension 172 (69%) 197 (78%) 0.014 
           TIA 44 (18%) 60 (24%) 0.08 
           Ischemic stroke  57 (23%) 56 (22%) 0.90 
           Hemorrhagic stroke 4 (2%) 4 (2%) 1.00 
           Myocardial infarction 13 (5%) 22 (9%) 0.12 
           Diabetes Mellitus 20 (8%) 46 (18%) 0.001 
Medication use    
           Antihypertensive drugs 117 (47%) 154 (61%) 0.001 
           Statins  114 (45%) 123 (49%) 0.45 
           Beta-blockers 81 (32%) 100 (40%) 0.08 
Systolic blood pressure – mmHg 138 (±19) 143 (±22) 0.013 
Diastolic blood pressure – mmHg 78 (±9) 78 (±10) 0.74 
BMI – m/kg2 26.5 (±4.1) 27.8 (±4.0) <0.001 
Alcohol intake – U/wk 7.3 (8.5) 8.4 (10.0) 0.19 
Smoking status     
           Never 75 (30%) 74 (29%) 0.90 
           Former 139 (55%) 140 (55%) 0.56 
           Active 37 (15%) 38 (15%) 0.92 
Executive functioning* 0.06 (±0.75) -0.07 (±0.77) 0.046 
Gaitspeed (m/s) 1.36 (±0.24) 1.18 (±0.32) <0.001 
Total MET-score 2006 – METhours/wk 97 [76-136] 37 [22-48] <0.001 
Total MET-score 2011 – METhours/wk (n=361) 65 [40-96] 34[17-59] <0.001 
Total MET-score 2015 – METhours/wk (n=296) 45 [26-82] 22 [9-40] <0.001 
Values are mean (± standard deviation), number (percentage) or median [interquartile range]. 
Abbreviations: TIA= Transient ischemic attack BMI = Body mass index; MET=Metabolic equivalent.  
† Beyond primary education  
* Based on the score of four cognitive tasks (i.e. fluency animals, fluency jobs, STROOP test and verbal 





Table 2. The effect of physical activity on MRI-markers – cross-sectional 
The reference group is the inactive group. All multivariate analyses were performed with correction for possible confounders at baseline. 
† For WMH volume a β is reported, all other outcomes are odds ratios.  
  
 Univariate    Multivariate   
MRI marker cSVD β or OR† 95% CI P-value  β or OR† 95% CI P-value 
WMH volume (ml) -1.88 -3.35 – -1.06 0.03  -1.05 -1.73 – 1.55 0.82 
Microbleeds present 0.76 0.47 – 1.22 0.25  0.88 0.53 – 1.44 0.60 
Lacunes present 0.45 0.30 – 0.67 <0.001  0.52 0.33 – 0.81 <0.01 
















The reference group is the inactive group. All statistical analyses were performed with correction for possible confounders at baseline. 
 
  
Variable Fixed effect estimate 95% CI P-value 
WMH volume -0.04 -2.31 –2.23  0.97 
Group*Year 2011  0.13 -1.02 – 1.29  0.82 
Group*Year 2015 -0.25 -1.51 –0.99 0.68 
    
Microbleeds (n) -0.18 -0.77 – 0.41 0.55 
Group*Year 2011  0.14 -0.26 – 0.53 0.50 
Group*Year 2015 -0.14 -0.58 – 0.29 0.52 
    
Lacunes (n) -0.18 -0.42 – 0.05 0.14 
Group*Year 2011  -0.02 -0.15 – 0.11 0.76 
Group*Year 2015 -0.17 -0.32 – -0.03 0.02 
    
SVD score (0-3) -0.13 -0.28 – 0.03 0.12 
Group*Year 2011  0.04 -0.05 – 0.13 0.38 





Table 4. The effect of physical activity on microstructural integrity – cross-sectional 
The reference group is the inactive group. All multivariate analyses were performed with correction for possible confounders at baseline. 
  
 Univariate    Multivariate   
Parameter β 95% CI P-value  β 95% CI P-value 
MD in WMLs (*10-3) -13.7 -32.2 – 4.82 0.15  -10.6 -28.7 – 7.40 0.25 
MD in NAWM (*10-3) -6.72 -15.9 – 2.54 0.15  -5.02 -11.7 – 1.62 0.14 
FA in WMLs (*10-3) -2.01 -11.5 – 7.49 0.68  -3.63 -13.2 – 5.93 0.46 

















The reference group is the inactive group. All statistical analyses were performed with correction for possible confounders at baseline. 
 
Variable Fixed effect estimate 95% CI P-value 
MD in WMLs -0.01 -0.03 – 0.01 0.35 
Group*Year 2011  0.001 -0.03 – 0.03 0.94 
Group*Year 2015 -0.0005 -0.03 – 0.03 0.97 
    
MD in NAWM -0.005 -0.015 – 0.005  0.32 
Group*Year 2011  0.0008 -0.011 – 0.012 0.88 
Group*Year 2015 0.004 -0.007 – 0.016 0.43 
    
FA in WMLs -0.003 -0.013 – 0.007 0.60 
Group*Year 2011  0.001 -0.010 – 0.012 0.82 
Group*Year 2015 0.002 -0.008 – 0.014 0.63 
    
FA in NAWM 0.003 -0.005 – 0.012 0.43 
Group*Year 2011  -0.0007 -0.011 – 0.010 0.88 
Group*Year 2015 -0.0002 -0.010 – 0.010 0.97 
